Merck Zocor has 59% market share at Henry Ford through market share discounts.
Executive Summary
ZOCOR HAS 59% HMG-CoA SHARE AT HENRY FORD HEALTH SYSTEM after the Merck and the health plan negotiated a preferred contract for the cholesterol-lowering agent, Henry Ford Hospital pharmacist Tony Petita reported at the Association for Pharmacoeconomics & Outcomes Research first annual meeting May 13 in Philadelphia. Merck's Zocor (simvastatin) was selected as Henry Ford's preferred cholesterol-lowering agent in the summer of 1995. Zocor had a 5% market share at Henry Ford in June 1994, one year before the switch.